Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics (NQ: CARA )

0.2860 +0.0189 (+7.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Analyst Ratings For Cara Therapeutics
Via Benzinga
Recap: Cara Therapeutics Q4 Earnings
Via Benzinga
A Preview Of Cara Therapeutics's Earnings
Via Benzinga
Why Paymentus Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of Paymentus Holdings, Inc. (NYSE: PAY) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth quarter financial results. 
Via Benzinga
CARA Stock Earnings: Cara Therapeutics Misses EPS, Misses Revenue for Q4 2023
CARA stock results show that Cara Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
From Cara Therapeutics, Inc.
Via GlobeNewswire
Earnings Scheduled For March 4, 2024
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is estimated to report earnings for its fourth quarter. 
Via Benzinga
Bullish Friday For Marijuana Stocks - Green Growth Brands, Elixinol Wellness Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Wednesday For Marijuana Stocks - Global Hemp Group, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For February 27, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 26, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money. 
Via InvestorPlace
Bullish Sentiment Across The Cannabis Space - Check Full Movers For February 23, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 21, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 15, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For February 14, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From February 13, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For February 12, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Movers For February 7, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For January 29, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For January 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
M Stock Alert: What to Know as Macy’s Rejects $5.8 Billion Buyout Offer
Macy's stock is up on Monday after the retail company rejected a $21 per share takeover offer for M stock valued at $5.8 billion. 
Via InvestorPlace
Cara Layoffs 2024: What to Know About the Latest CARA Job Cuts
Cara Therapeutics layoffs have the biopharmaceutical company preparing to cut 50% of its workers to extend its cash runway to 2026. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Movers For January 19, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.